---

Role of platelet rich plasma in chronic plantar fasciitis: An outcome analysis

Full Text PDF

---

Original Article

Author Details : Snehashish Mukherjee*, D K. Taneja, H Safderi

Volume : 5, Issue : 2, Year : 2019

Article Page : 114-117

https://doi.org/10.18231/j.ijos.2019.021

Suggest article by email

Get Permission

Abstract

Introduction: plantar fasciitis is most common cause of chronic heel pain. Platelet rich plasma is a new treatment modality that can be beneficial in refractory cases. The purpose of this study is to determine the effectiveness and safety of local PRP injection in plantar fasciitis.
Materials and Methods: Thirty-two cases (23 females and 9 males) were treated by local injection of PRP at heel in Arihant Hospital and Research Centre, Indore between October 2016 to September 2017 and followed-up in this prospective study. AOFAS hind foot score and Roles-Maudsley score were used to determine improvement in pain.
Results: The mean age of the patients was 45.71±12.1 years (range 23-67 years) and female dominant. Mean duration of symptoms was 11.7±6.7 months (range 6 months to 24 months). Only patients having symptoms for more than 3 months with no relief from conservative treatment were involved in study. The initial mean AOFAS hind foot score, 44.41 ± 3.25 improved to 91.31 ± 7.37 at 9 month follow up, which was statistically significant (p<0>90.6% patients having good to excellent roles-maudsley score at 9 month follow up. Four patients required a repeat injection at 3 months, from which one patient showed no improvement while rest had significant improvement.
Conclusion: local injection of Platelet rich plasma is an effective and safe method in refractory cases of plantar fasciitis.

Keywords: Plantar fasciitis, Heel pain, Platelet rich plasma.

How to cite : Mukherjee S, Taneja D K, Safderi H, Role of platelet rich plasma in chronic plantar fasciitis: An outcome analysis. Indian J Orthop Surg 2019;5(2):114-117

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.